November 1, 2021
Foundation Research Scholar Reports Progress in Project Focused on Peritoneal Spread
Gesundheit Superfoods: Tomatoes

Chef Hans Rueffert loves this superfood not only for its versatility in the kitchen but also for its wide variety of health benefits! While Hans prepares a tomato and burrata salad, listen to Dr. Ellen Steinberg share more on the many reasons to love tomatoes.
Mark Your Calendar:
The Gesundheit Kitchen LIVESTREAM
Thursday, November 18th
12pm PST/3pm EST
Streaming at and Facebook.
Research Roundup
Here are some recent advances in the quest to find new treatments for gastric cancer.

Adding FivePrime’s experimental first-in-class FGFR2b-targeted drug to chemotherapy significantly improved responses and survival over chemotherapy alone in a trial reported during the 2021 ASCO Annual Meeting.

Japanese researchers found a source of genomic instability in Helicobacter Pylori that may explain the link between gastric cancer and chronic infection with the stomach bug. The researchers also discovered a potential method for regulating cancer cell proliferation to improve the treatment of gastric cancer with DNA-damaging agents like chemotherapy.

The FDA granted orphan drug designation to Bold Therapeutics to help ease the regulatory pathway for BOLD-100, a first-in-class ruthenium-based drug being developed to treat gastric cancer. BOLD-100 modifies the “unfolded protein response,” damaging the DNA of cancer cells and causing them to die. It’s being tested in combination with chemotherapy.
Quick Links to Resources
Special Thanks to Our
National Sustaining Sponsors
Spread the word. Share the Gastric Cancer Foundation Newsletter.